Related Experiment Videos
An adolescent with IgA nephropathy and Crohn disease: pathogenetic implications
Tsukasa Takemura1, Mitsuru Okada, Kazuro Yagi
1Department of Pediatrics, Kinki University School of Medicine, 377-2, Ohno-Higashi, Osaka-Sayama, 589-8511, Japan. tsukasa@med.kindai.ac.jp
Pediatric Nephrology (Berlin, Germany)
|October 12, 2002
Summary
This study details a patient with IgA nephropathy and Crohn disease, showing their linked clinical courses. Treatment targeting the immune response improved both conditions, suggesting a shared cause.
Area of Science:
- Immunology
- Nephrology
- Gastroenterology
Background:
- Immunoglobulin A (IgA) nephropathy is a kidney disease.
- Crohn disease is a chronic inflammatory bowel disease.
Observation:
- A patient developed IgA nephropathy at age 10, treated successfully with immunosuppressants and ACE inhibitors.
- At age 13, the patient developed Crohn disease, with recurrence of IgA nephropathy and elevated serum IgA levels correlating with disease activity.
Findings:
- Combined therapy with an elemental diet and oral prednisolone led to clinical improvement in Crohn disease.
- This treatment also achieved remission of IgA nephropathy and normalized serum IgA levels.
Implications:
- The linked clinical course suggests a common pathogenetic mechanism between IgA nephropathy and Crohn disease.
- This mechanism likely involves an IgA immune response to intestinal mucosal challenges.
- Further research into this link could reveal new therapeutic targets for both conditions.